Skip to main content
. Author manuscript; available in PMC: 2017 Dec 21.
Published in final edited form as: Neuromolecular Med. 2016 Jul 7;19(1):46–56. doi: 10.1007/s12017-016-8423-9

Fig. 3.

Fig. 3

Concentrations of lactosylcermide species and hexosylceramide species measured in 100 μl plasma samples obtained from type 1 diabetes patients with (n = 19) and without (n = 61) self-reported neuropathy using mass spectroscopy. Upper panel lactosylcermide species; lower panel hexosylceramide species. Data presented as mean + standard deviation